Related Experiment Video

Updated: Jul 6, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Activated NF-kB in colorectal cancer: predictive or prognostic factor?

Giovanni Brandi, Maria A Pantaleo, Guido Biasco

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |March 8, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    Related Concept Videos

    NF-κB-dependent Signaling Pathway02:26

    NF-κB-dependent Signaling Pathway

    The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
    NF-κB-dependent Signaling Mechanism
    The heterodimer of NF-κB...

    Articles linked to this work by shared authors, journal, and citation graph.

    Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysis.

    Clinical & experimental metastasis·2026

    PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-Analysis.

    JAMA oncology·2026

    Efficacy of Adding Immune Checkpoint Inhibition to Chemotherapy, With or Without VEGF Inhibition, in Patients With Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient Data.

    JTO clinical and research reports·2026

    The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and Diabetes.

    Oncology research·2026

    Integrative genomic and immune landscape analysis of intimal sarcomas for emerging therapeutic targets and immunotherapy strategies.

    Frontiers in immunology·2026

    The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells.

    Frontiers in oncology·2026

    COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Assessment of drug utilization patterns and associated survival outcomes in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Insights from a resource-constrained set-up.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

    Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT in Gastric Cancer: Impact on Metastatic Detection and Stage Migration.

    The British journal of radiology·2026

    Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer.

    Cancer research·2026

    Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.

    Journal of the National Cancer Institute·2026

    Occupational Differences in Opioid-Related Overdose Deaths: A Retrospective Descriptive Analysis.

    Substance use & misuse·2026

    Coexpression network analysis of gastric adenocarcinoma identifies hub genes as biomarker candidates and their tumor microenvironment associations.

    Genetics and molecular biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us